GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BerGenBio ASA (FRA:7BG0) » Definitions » Effect of Exchange Rate Changes

BerGenBio ASA (FRA:7BG0) Effect of Exchange Rate Changes : €0.37 Mil (TTM As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BerGenBio ASA Effect of Exchange Rate Changes?

BerGenBio ASA's Effect of Exchange Rate Changes for the three months ended in Sep. 2024 was €0.20 Mil.

BerGenBio ASA's Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Sep. 2024 was €0.37 Mil.


BerGenBio ASA Effect of Exchange Rate Changes Historical Data

The historical data trend for BerGenBio ASA's Effect of Exchange Rate Changes can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BerGenBio ASA Effect of Exchange Rate Changes Chart

BerGenBio ASA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Effect of Exchange Rate Changes
Get a 7-Day Free Trial Premium Member Only 0.03 -0.07 -0.08 -0.36 0.24

BerGenBio ASA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Effect of Exchange Rate Changes Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.11 -0.09 0.30 -0.04 0.20

BerGenBio ASA Effect of Exchange Rate Changes Calculation

Effect of Exchange Rate Changes represents the effect of exchange rate changes on cash balances held in foreign currencies.

Effect of Exchange Rate Changes for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BerGenBio ASA Effect of Exchange Rate Changes Related Terms

Thank you for viewing the detailed overview of BerGenBio ASA's Effect of Exchange Rate Changes provided by GuruFocus.com. Please click on the following links to see related term pages.


BerGenBio ASA Business Description

Industry
Traded in Other Exchanges
Address
Mollendalsbakken 9, Bergen, NOR, 5009
BerGenBio ASA is a clinical-stage biopharmaceutical Company focused on developing novel medicines for aggressive diseases. The company's clinical asset, bemcentinib, targeting the receptor tyrosine kinase AXL, is currently in development in a Ph1b/2a study in 1L STK 11 mutated NSCLC and preclinical development for severe respiratory infections.

BerGenBio ASA Headlines

No Headlines